CENTENNIAL, Colo., April 29 /PRNewswire/ -- LABS Inc., one of the premier transplant reference and consultative laboratories in the country, announced today that it has added Chad J. Ronholdt, an innovator in the medical device and orthobiologic industries, to its executive team as Director of Business Development.
Ronholdt has led a distinguished career in the field of medical devices and biologics for 13 years, with a solid record of transforming fundamental scientific concepts into effective products used by surgeons worldwide. He has worked with various tissue allograft and orthopaedic medical device producers as well as several research laboratories in both scientific and strategic capacities. He also served as the Chair of the American Association of Tissue Banks (AATB) Scientific and Technical Affairs Committee from 2005 to 2008.
His most recent position was Director of Research and Development at AlloSource, one of the nation’s largest non-profit providers of tissue allografts for use in surgical procedures. In this role Ronholdt was the primary inventor on three patent-pending platform technologies that greatly enhance allograft safety and was a co-inventor on a specialized allograft designed for spine surgeries. He was also responsible for the exploration, identification and evaluation of new technologies and product concepts that advanced the company’s intellectual property and product offering portfolio.
As the Director of Business Development at LABS Inc., Ronholdt will be responsible for maintaining and building existing client service offerings as well as expanding into more innovative markets not currently served by LABS Inc. He will work with the AATB and other allograft agencies to develop new offerings for the tissue testing product line and Ronholdt will be working directly with medical device companies and other manufacturers to develop new product offerings to meet their needs.
“I am proud to announce the hire of Chad Ronholdt, a dedicated microbiologist, researcher, executive and medical device innovator,” said Elizabeth Hearty, Chief Executive Officer of LABS Inc. “I am confident Chad’s keen eye for development strategy and rich background in science will make him an important asset for LABS Inc. moving forward.”
LABS Inc. has been serving the transplant community for more than 25 years in the areas of infectious disease, immunogenetics and microbiology bringing unparalleled consultative and regulatory expertise to its customers. The company has earned a reputation as an industry leader through a strong track record of quality and accurate testing, the use of cutting-edge technology for new, timelier and more accurate tests and its unsurpassed, hands-on service.
About LABS Inc.
LABS Inc. is a premier transplant medicine reference laboratory bringing unparalleled consultative expertise and industry knowledge to its clients. Testing is focused on donor eligibility determination and final product safety; infectious disease testing, microbiology, histocompatibilty and environmental monitoring. LABS Inc. is committed to respectfully fulfilling the wishes of donors by ensuring the gift is able to generate positive patient outcomes. LABS Inc. employs over 100 people. The company is located in Centennial, CO with satellite facilities in St. Louis, MO and Philadelphia, PA.
CONTACT: Jennifer Tramontana of The Fletcher Group, +1-303-929-9636,
jennifer@fletchergroupllc.com, for LABS Inc.
